We are live on ! Find out more
NKGNW

NKGen Biotech, Inc. Warrants
NKGNW

Delisted

NKGNW was delisted on the 4th of March, 2025.

Back to rankings

37 hedge funds and large institutions have $397K invested in NKGen Biotech, Inc. Warrants in 2023 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 3 increasing their positions, 6 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more first-time investments, than exits

New positions opened: 1 | Existing positions closed: 1

3% less funds holding

Funds holding: 38 → 37 (-1)

50% less repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 6

72% less capital invested

Capital invested by funds: $1.43M → $397K (-$1.03M)

Holders
37
Holders Change
-1
Holders Change %
-2.63%
% of All Funds
0.59%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
3
Reduced
6
Closed
1
Calls
$25K
Puts
–
Net Calls
+$25K
Net Calls Change
+$10K

Top Buyers

Rank Fund Capital Flow
1
ETH
Exos TFP Holdings
New York
+$2.65K
2
SCM
Shaolin Capital Management
Florida
+$2.16K
3
FTUS
Flow Traders U.S.
New York
+$1.63K
4
Walleye Capital
Walleye Capital
New York
+$455

Top Sellers

Rank Fund Capital Flow
1
SG
StoneX Group
New York
-$3.73K
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$619
3
CH
CVI Holdings
Delaware
-$514
4
GF
Gabelli Funds
New York
-$407
5
AA
AQR Arbitrage
Connecticut
-$333

NKGNW Hedge Fund Activity: Q1 2023 in Review

37 of the 6,283 institutional investors tracked by Wall St. Rank reported a position in NKGen Biotech, Inc. Warrants (NKGNW) for Q1 2023, worth a combined $397K — down 72% from $1.43M a quarter earlier.

Fund positioning in NKGNW was balanced in Q1 2023: 1 fund opened new positions, 1 closed out, 3 added to existing stakes and 6 trimmed.

The largest buyer was Exos TFP Holdings, adding an estimated $2.65K. The largest seller was StoneX Group, cutting an estimated $3.73K.

  • 37 institutional investors held NKGen Biotech, Inc. Warrants (NKGNW) as of Q1 2023, down from 38 in Q4 2022.
  • Funds reported $397K of NKGen Biotech, Inc. Warrants stock for Q1 2023, down 72% quarter-over-quarter.
  • 1 fund opened new NKGen Biotech, Inc. Warrants positions in Q1 2023 and 1 closed out, a net change of 0 holders.
  • The largest NKGen Biotech, Inc. Warrants buyer in Q1 2023 was Exos TFP Holdings, an estimated $2.65K added.
  • The largest NKGen Biotech, Inc. Warrants seller in Q1 2023 was StoneX Group, an estimated $3.73K sold.

Based on aggregated 13F filings for Q1 2023.